Current Perspectives for the use of Gonane Progesteronergic Drugs in the Treatment of Central Hypoventilation Syndromes

BACKGROUND: Central alveolar hypoventilation syndromes (CHS) encompass neurorespiratory diseases resulting from congenital or acquired neurological disorders. Hypercapnia, acidosis, and hypoxemia resulting from CHS negatively affect physiological functions and can be life-threatening. To date, the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Loiseau, Camille, Cayetanot, Florence, Joubert, Fanny, Perrin-Terrin, Anne-Sophie, Cardot, Philippe, Fiamma, Marie-Noëlle, Frugiere, Alain, Straus, Christian, Bodineau, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295933/
https://www.ncbi.nlm.nih.gov/pubmed/28721821
http://dx.doi.org/10.2174/1570159X15666170719104605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295933/
https://www.ncbi.nlm.nih.gov/pubmed/28721821
http://dx.doi.org/10.2174/1570159X15666170719104605

Ejemplares similares